Breakthrough EU approval for Dupixent offers new hope for children with eosinophilic esophagitis

Pallavi Madhiraju- November 8, 2024 0

The European Medicines Agency (EMA) has granted approval for Dupixent, a therapy developed by Sanofi and Regeneron, to treat eosinophilic esophagitis (EoE) in children as ... Read More